Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Polymorphism of stromal cell-derived factor-1 selectively upregulates gene expression and is associated with increased susceptibility to coronary artery disease.

Gu XL, Ma N, Xiang DC, Huang J, Dong ZH, Lei HY, Ding R, Gong ZH, Wen YF, Qiu J, Ma L.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):932-7. doi: 10.1016/j.bbrc.2013.12.065. Epub 2013 Dec 19.

PMID:
24361877
2.

CD14 promoter polymorphism (- 159C-->t) is not associated with myocardial infarction or coronary artery disease in patients with assumed high genetic risk.

Haberbosch W, Unkelbach K, Schuster D, Gardemann A, Tillmanns H, Hölschermann H.

Thorac Cardiovasc Surg. 2009 Oct;57(7):386-90. doi: 10.1055/s-0029-1185876. Epub 2009 Sep 30.

PMID:
19795323
3.

Association of CXCL12 and CXCR4 gene polymorphisms with the susceptibility and prognosis of renal cell carcinoma.

Cai C, Wang LH, Dong Q, Wu ZJ, Li MY, Sun YH.

Tissue Antigens. 2013 Sep;82(3):165-70. doi: 10.1111/tan.12170.

PMID:
24032722
4.

Stromal cell-derived factor-1-3'A polymorphism is associated with decreased risk of myocardial infarction and early endothelial disturbance.

Borghini A, Sbrana S, Vecoli C, Mercuri A, Turchi S, Carpeggiani C, L'Abbate A, Andreassi MG.

J Cardiovasc Med (Hagerstown). 2014 Sep;15(9):710-6. doi: 10.2459/JCM.0000000000000068.

PMID:
24751515
5.

An association study of thrombospondin 1 and 2 SNPs with coronary artery disease and myocardial infarction among South Indians.

Ashokkumar M, Anbarasan C, Saibabu R, Kuram S, Raman SC, Cherian KM.

Thromb Res. 2011 Oct;128(4):e49-53. doi: 10.1016/j.thromres.2011.05.026. Epub 2011 Jul 16.

PMID:
21762961
6.

CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes.

Arroyo-Espliguero R, El-Sharnouby K, Vázquez-Rey E, Kalidas K, Jeffery S, Kaski JC.

Int J Cardiol. 2005 Feb 15;98(2):307-12.

PMID:
15686783
7.

T-786C polymorphism in the endothelial nitric oxide synthase gene is associated with increased risk of coronary artery disease in a Chinese population.

Han Y, Xu W, Zhang W, Liu N, Ji Y.

Pharmacology. 2010;85(4):211-6. doi: 10.1159/000275135. Epub 2010 Mar 6.

PMID:
20215811
8.

C(-260)-->T polymorphism in the promoter of the CD14 monocyte receptor gene as a risk factor for myocardial infarction.

Hubacek JA, Rothe G, Pit'ha J, Skodová Z, Stanĕk V, Poledne R, Schmitz G.

Circulation. 1999 Jun 29;99(25):3218-20. Erratum in: Circulation 1999 Dec 21-28;100(25):2550.

9.

Influence of renin-angiotensin system gene polymorphisms on the risk of ST-segment-elevation myocardial infarction and association with coronary artery disease risk factors.

Konopka A, Szperl M, Piotrowski W, Roszczynko M, Stępińska J.

Mol Diagn Ther. 2011 Jun 1;15(3):167-76. doi: 10.2165/11590650-000000000-00000.

PMID:
21657802
10.

CD14 C(-260)-->T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections and risk of stable coronary artery disease.

Koenig W, Khuseyinova N, Hoffmann MM, März W, Fröhlich M, Hoffmeister A, Brenner H, Rothenbacher D.

J Am Coll Cardiol. 2002 Jul 3;40(1):34-42.

11.

The impact of the stromal cell-derived factor-1-3'A and E-selectin S128R polymorphisms on breast cancer.

Kontogianni P, Zambirinis CP, Theodoropoulos G, Gazouli M, Michalopoulos NV, Flessas J, Liberi M, Zografos GC.

Mol Biol Rep. 2013 Jan;40(1):43-50. doi: 10.1007/s11033-012-1989-x. Epub 2012 Nov 6.

PMID:
23129313
12.

CD36 mRNA expression is increased in CD14+ monocytes of patients with coronary heart disease.

Teupser D, Mueller MA, Koglin J, Wilfert W, Ernst J, von Scheidt W, Steinbeck G, Seidel D, Thiery J.

Clin Exp Pharmacol Physiol. 2008 May;35(5-6):552-6. Epub 2007 Dec 7.

PMID:
18067591
13.

Association of RANTES G-403A gene polymorphism with increased risk of coronary arteriosclerosis.

Simeoni E, Winkelmann BR, Hoffmann MM, Fleury S, Ruiz J, Kappenberger L, März W, Vassalli G.

Eur Heart J. 2004 Aug;25(16):1438-46.

PMID:
15302103
14.

The association of interleukin-16 gene polymorphisms with susceptibility of coronary artery disease.

Huang H, Zeng Z, Zhang L, Liu R, Li X, Qiang O, Zhang Q, Chen Y.

Clin Biochem. 2013 Feb;46(3):241-4. doi: 10.1016/j.clinbiochem.2012.11.009. Epub 2012 Nov 27.

PMID:
23195133
15.

G801A polymorphism of human stromal cell-derived factor 1 gene raises no susceptibility to neoplastic lesions of uterine cervix.

Tee YT, Yang SF, Wang PH, Tsai HT, Lin LY, Lee SK, Liao CL, Chang JT, Shih YT.

Int J Gynecol Cancer. 2012 Oct;22(8):1297-302.

PMID:
22954782
16.

Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control study.

Galluzzo S, Patti G, Dicuonzo G, Di Sciascio G, Tonini G, Ferraro E, Spoto C, Campanale R, Zoccoli A, Angeletti S.

Hum Immunol. 2011 Aug;72(8):636-40. doi: 10.1016/j.humimm.2011.04.005. Epub 2011 Apr 29.

PMID:
21565239
17.

Study of the association between growth differentiation factor 15 gene polymorphism and coronary artery disease in a Chinese population.

Chen Z, Xie F, Ma G, Feng Y, Qian Q, Liu N.

Mol Biol Rep. 2011 Nov;38(8):5085-91. doi: 10.1007/s11033-010-0655-4. Epub 2011 Feb 11.

PMID:
21312063
18.

Impact of MCP-1 and CCR-2 gene polymorphisms on coronary artery disease susceptibility.

Lin HL, Ueng KC, Hsieh YS, Chiang WL, Yang SF, Chu SC.

Mol Biol Rep. 2012 Sep;39(9):9023-30. doi: 10.1007/s11033-012-1773-y. Epub 2012 Jul 3.

PMID:
22752804
19.

Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population.

Gao J, Shao Y, Lai W, Ren H, Xu D.

J Hum Genet. 2010 Oct;55(10):668-75. doi: 10.1038/jhg.2010.85. Epub 2010 Jul 29.

PMID:
20668462
20.

Association of chemokine CXCL12-3'G801A polymorphism with systemic lupus erythematosus in a Han Chinese population.

Wu FX, Luo XY, Wu LJ, Yang MH, Long L, Liu NT, Zhou B, Zeng XF, Yang CD, Yuan GH.

Lupus. 2012 May;21(6):604-10. doi: 10.1177/0961203311435266. Epub 2012 Feb 6.

PMID:
22311941

Supplemental Content

Support Center